Back
Greenpro Capital Vs. Corcept Therapeutics Industry Stock Comparison
Sell
31
GRNQ
Greenpro Capital
Last Price:
$0.87
Seasonality Move:
32.57%
Sell
46
CORT
Corcept Therapeutics
Last Price:
$68.59
Seasonality Move:
2.94%
Sell
31
Greenpro Capital (GRNQ)
is a Sell
Is Greenpro Capital a Buy, Sell or Hold?
-
The current Greenpro Capital [GRNQ] share price is $0.87. The Score for GRNQ is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
-
GRNQ is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
46
Corcept Therapeutics (CORT)
is a Sell
Is Corcept Therapeutics a Buy, Sell or Hold?
-
The current Corcept Therapeutics [CORT] share price is $68.62. The Score for CORT is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
-
CORT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
GRNQ Stock Price Chart
What is Greenpro Capital's stock price today?
-
The Greenpro Capital share price today is $0.87Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GRNQ is experiencing selling pressure, which indicates risk of future bearish movement.
CORT Stock Price Chart
What is Corcept Therapeutics's stock price today?
-
The Corcept Therapeutics share price today is $68.62The current trend is moderately bullish and CORT is experiencing buying pressure, which is a positive indicator for future bullish movement.
GRNQ Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.02 | Sell |
| Relative Strength Index (14 RSI): | 43.22 | Sell |
| Chaikin Money Flow: | -4528 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.88 - 0.94) | Sell |
| Bollinger Bands (100): | (0.89 - 1.15) | Sell |
CORT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 15.73 | Buy |
| Relative Strength Index (14 RSI): | 50.15 | Buy |
| Chaikin Money Flow: | 963031 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (51.81 - 80.17) | Buy |
| Bollinger Bands (100): | (51.04 - 70.1) | Buy |
GRNQ Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.89 | Sell |
| 20-day SMA: | 0.9 | Sell |
| 50-day SMA: | 0.96 | Sell |
| 200-day SMA: | 0.99 | Sell |
| 8-day EMA: | 0.88 | Sell |
| 20-day EMA: | 0.9 | Sell |
| 50-day EMA: | 0.95 | Sell |
| 200-day EMA: | 1.03 | Sell |
CORT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 74.01 | Sell |
| 20-day SMA: | 68.65 | Sell |
| 50-day SMA: | 65.66 | Buy |
| 200-day SMA: | 49.93 | Buy |
| 8-day EMA: | 71.22 | Sell |
| 20-day EMA: | 59.16 | Buy |
| 50-day EMA: | 35.29 | Buy |
| 200-day EMA: | 11.08 | Buy |
Greenpro Capital Earnings Growth & GRNQ Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Corcept Therapeutics Earnings Growth & CORT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.22 per share, a decrease next quarter of $0.04 per share, an increase this year of $0.29 per share, and an increase next year of $1.64 per share.
Greenpro Capital Technical Analysis
| Mar 31 | Apr 1 | Apr 2 | Apr 3 | Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 31 | 01 | 02 | 03 | 04 | 07 | 08 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Corcept Therapeutics Technical Analysis
| Mar 31 | Apr 1 | Apr 2 | Apr 3 | Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 31 | 01 | 02 | 03 | 04 | 07 | 08 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||